ProfileGDS5678 / 1455645_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 18% 80% 82% 27% 28% 26% 27% 28% 59% 28% 28% 28% 28% 20% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.4636218
GSM967853U87-EV human glioblastoma xenograft - Control 25.7243980
GSM967854U87-EV human glioblastoma xenograft - Control 35.9829482
GSM967855U87-EV human glioblastoma xenograft - Control 42.5760527
GSM967856U87-EV human glioblastoma xenograft - Control 52.5985928
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.6673626
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.656227
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.6283728
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.5286859
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.6287328
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.6385228
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.6133328
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.6422428
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.4607720